Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: Belimumab for the treatment of early diffuse systemic sclerosis: Results of a randomized, double-blind, placebo-controlled, pilot trial. Have a read: https://www.m3india.in/contents/journal/belimumab-for-the-treatment-of-early-diffuse?utm_campaign=unset&utm_medium=share&utm_source=ref_wa